| Literature DB >> 15986432 |
Xiu-Mei Cai1, Bei-Bei Tao, Li-Ying Wang, Yu-Long Liang, Jia-Wei Jin, Yong Yang, Ya-Li Hu, Xi-Liang Zha.
Abstract
PTEN is a major tumor suppressor gene that has been shown to inhibit cell invasion. Its mutation has been found in 20-40% of malignant gliomas. Meanwhile, the type III EGFR mutation (EGFRvIII), which was frequently found in gliomas, promoted cell invasion. In the present study, the effects of PTEN on cell invasion were investigated in U87DeltaEGFR glioblastoma cells with EGFRvIII expression but missing PTEN. The cell invasion was downregulated by transfection of phosphatase-active forms of PTEN (wild-type and G129E) but not by PTEN (C124A) with an inactive phosphatase domain; the effects were correlated with decreased tyrosine phosphatase levels of FAK at Tyr397, which was increased by EGFRvIII. Overexpression of FAK mutant (Y397F) could partially mimic the effect of PTEN on cell invasion. Although EGFRvIII increased the levels of P-Akt and PTEN eliminated it, PI-3K inhibitors, wortmannin or Ly294002, could not decrease the cell invasion. In conclusion, PTEN could inhibit cell invasion even in the presence of the constitutively active EGFR; this inhibition depended on its protein phosphatase activity, partially by dephosphorylating FAK, but not depended on its lipid phosphatase activity. Copyright 2005 Wiley-Liss, IncEntities:
Mesh:
Substances:
Year: 2005 PMID: 15986432 DOI: 10.1002/ijc.21251
Source DB: PubMed Journal: Int J Cancer ISSN: 0020-7136 Impact factor: 7.396